Interferon-alfa Treatment of Essential Thrombocythemia during Pregnancy
نویسندگان
چکیده
منابع مشابه
Essential thrombocythemia and pregnancy.
+39.79.228375. Fax. international +39.79.228282. Received January 17, 1995; accepted February 27, 1995. Sir, the management of essential thrombocythemia (ET) in young patients is still controversial and represents an intriguing problem especially, during pregnancy. We have read with interest the article by Radaelli et al., which reports a concise review of published data on the course of pregna...
متن کاملPegylated interferon for the treatment of high-risk essential thrombocythemia.
Acute Myeloid Leukemia 1339-1345 Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome having chromosome 5 and/or 7 abnormalities Hanneke M. van der Straaten, Anja van Biezen, Ronald Brand, Anton V.M.B. Schattenberg, Roel M. Egeler, Renée M. Barge, Jan J. Cornelissen, Harry C. Schouten, Gert J. Ossenkoppele, Leo F. Verdonck on behalf of the Ne...
متن کاملPegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
Pregnant woman with essential thrombocythemia (ET) are at higher than normal risk of pregnancy complications. Current recommendations suggest that aspirin and cytoreductive therapy should be offered for high-risk pregnancies but Pegylated interferon alpha-2a (PEG-IFN) has never been investigated in this context. From our case series, including 10 pregnancies, we demonstrate that PEG-IFN has bee...
متن کاملPegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.
BACKGROUND AND OBJECTIVES Patients with high-risk essential thrombocythemia require cytoreductive therapy in order to normalize the elevated platelet counts. We evaluated the efficacy and toxicity of pegylated interferon in high-risk essential thrombocythemia in a phase II trial. DESIGN AND METHODS Thirty-six patients with high-risk essential thrombocythemia (median age 54 years; range, 24-72...
متن کاملLymphoblastoid interferon alfa treatment in chronic hepatitis
Interferon is becoming the standard treatment in adults for chronic hepatitis C. Twenty one children with histologically proved chronic hepatitis C (10 boys, range 2 5-13 years), who were otherwise healthy, were enrolled in a randomised controlled study to test their response to interferon alfa. Eleven children were treated with lymphoblastoid interferon alfa (3 million units/M2) for 12 months;...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine
سال: 2006
ISSN: 0918-2918,1349-7235
DOI: 10.2169/internalmedicine.45.1879